Skip to main content
. 2022 Aug 31;112(5):1285–1295. doi: 10.1002/JLB.5VMR0322-161R

TABLE 1.

Models for the study of CNS latent reservoirs

Human clinical samples Macaque models Rodent models

Advantages

  • True representation of CNS cell types needed to study HIV reservoirs
  • All cell types of human origin and real reflection of the disease time course
  • Prefect for therapeutic targeting and reliable disease outcome from longitudinal studies

Advantages

  • Macaques are closer to humans in terms of physiologic make up
  • SIV infection of macaques follow a progressive disease pattern similar to that of humans
  • SIV infection in primates respond to cART therapy as like in humans
  • Myeloid reservoir cell types from CNS can be isolated at different time points to study and perform long‐term in vitro mechanistic studies
  • Larger animal size allows more sample collection at a particular time point
  • Both HIV and SIV have similar histone acetylation pattern in the brain
  • Replication‐competent virus carrying macrophages were reported in macaques
  • Cells of myeloid origin have more or less similar distribution in HIV and SIV

Advantages

  • HIV‐infected humanized mice have shown hall mark signs of HIV infection in the brain such as neuronal death, neurocognitive impairments and activation of microglia
  • Microglia and lymphocytes in humanized mice represent brain reservoir
  • Replication‐competent virus was isolated from virally suppressed humanized mice brains and shown to establish fresh infection in new humanized mice
  • Fewer brain cells are required to perform QVOA in humanized mice for validation of HIV cure studies
  • Myeloid cells isolated from MoM mice have been shown to carry and spread viral infection independent of T cells
  • Low cost maintenance and these colonies can be established around the world for any longitudinal studies
  • Shorter duration to get accurate data on any proposed model to look at CNS reservoirs
  • Have a complete functional human immune system, which lasts up to 1 year for any neurologic and CNS reservoir studies

Limitations

  • Difficult to obtain CNS samples
  • The variability of the timing of infection and comorbidities
  • Variability in viral load and immune cell expression because of recent late‐stage patients
  • Variability of therapeutic approaches
  • most studies on microglia are limited to primary cultures or from postmortem brains, which may not reflect latent reservoirs as in living patients

Limitations

  • SIV and HIV virus are not identical genetically and have differential response in disease progression
  • Larger differences in MHC genes between humans and macaques
  • Macaques have different innate immune factors that control SIV replication as compared to humans
  • High cost and maintenance for any proposed CNS studies
  • Primate research facility availability is scarce around the world for CNS and reservoir studies
  • CNS reservoirs get established much earlier (∼3 days) than in other models
  • SIV viral loads are much higher in brains of macaques as compared to humans so studying latency is a challenge
  • Vpx protein in SIV have been shown to reduce a myeloid restriction factor leading to higher level of infection in myeloid cells, as compared with other HIV model studies

Limitations

  • ‐Collection of lesser volume of samples during intermediate time point of analysis
  • ‐Need sterile environment for HIV‐specific CNS studies on severely immunodeficient mice
  • ‐Graft‐versus‐host disease in some humanized mice models based on transplantation of human hematopoietic stem cells